Drug intelligence / Profile preview

pleurotus tuberregium

Development stage
Phase 2
Modality
Recombinant Proteins and Enzymes, Peptides, Small Molecules
Administration
Oral, Ophthalmic
01

Overview

*Pleurotus tuberregium*, also known as the King Tuber mushroom, is an edible macro-fungus found in tropical regions, notably West Africa and Southeast Asia. It is unique among Pleurotus species for producing a sclerotium (an underground tuber-like storage organ) which is widely used in traditional medicine, particularly in Nigeria (where it is known as "usu"). Research into its sclerotia and fruiting bodies has revealed a diverse range of bioactive compounds, including beta-glucans, flavonoids (quercetin, kaempferol, luteolin), phenolic acids (caffeic acid, chlorogenic acid), and phytosterols (sitosterol). Pre-clinical animal studies suggest significant therapeutic potential for managing diabetes mellitus, hypertension, and hypercholesterolemia, as well as providing hepatorenal protection against toxins like carbon tetrachloride and paracetamol. Its pharmacologic effects are likely multi-target, involving the modulation of electrolyte levels (sodium and potassium), inhibition of HMG-CoA reductase, and activation of endogenous antioxidant pathways.

Other names
King Tuber mushroomKing Tuber medicinal mushroomusuPleurotus tuber-regium
02

Targets

mAChR (Muscarinic acetylcholine receptors)HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)

Beyond the preview

Go deeper on pleurotus tuberregium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pleurotus tuberregium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call